Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530101 · ClinicalTrials.gov registry record · Phase 1
The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00530101: Completed Phase 1 study, sponsored by University of Miami.
NCT00530101 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530101, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate MR imaging in subjects receiving doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA scans. This research study is expected to enroll approximately 10 subjects over 12 months at the University of Miami / Miller School of Medicine.
Interventions
- DRUG Doxorubicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
What the finished NCT00530101 record still lists
NCT00530101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Doxorubicin is the first listed.
NCT00530101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00530101 about?
NCT00530101 is a clinical study titled "The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity". The purpose of this research study is to evaluate MR imaging in subjects receiving doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA scans. This research study is expected to enroll approximately 10 subjects over 12 months at the University of Miami / Mill...
What is the current status of trial NCT00530101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2004-07. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00530101?
The interventions under investigation include: Doxorubicin (DRUG).
Who is sponsoring clinical trial NCT00530101?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00530101's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia